National Resilience Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, and Taiwan Bio-Manufacturing Corporation (TBMC), have announced a joint venture which aims to transform the biomanufacturing industry—addressing the growing need for technology-enabled, end-to-end solutions for complex medicines.   In recent years, the biomedical industry has made incredible strides in developing increasingly complex medicines. However, large-scale bioma...